CFDE Data Portal | Search CTAGE7P

	Label	Description
	CTAGE7P associations Collection (Entity type)	Associations for CTAGE7P_associations
	CTAGE7P associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CTAGE7P Gene (Entity type)	ENSG00000233122 - CTAGE family member 7, pseudogene
	GSE196343 metformin 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 8 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 8 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172219 adenosine 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE113655 phenol 3 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 9 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS

CTAGE7P associations

Associations for CTAGE7P_associations

CTAGE7P associations.tsv

A file from IDG as part of the Harmonizome project

CTAGE7P

ENSG00000233122 - CTAGE family member 7, pseudogene

GSE196343 metformin 1 v 0 human dn

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 0 v 1 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 8 v 5 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 8 v 7 human dn

A Gene Set from LINCS

GSE172219 adenosine 0 v 1 human dn

A Gene Set from LINCS

GSE113655 phenol 3 v 4 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 9 v 5 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.